Endoscopic Local Excision (ELE) with Knife-Assisted Resection (KAR) Techniques Followed by Adjuvant Radiotherapy and/or Chemotherapy for Invasive (T1bsm2,3/T2) Early Rectal Cancer: A Multicenter Retrospective Cohort.

IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
George Tribonias, Apostolis Papaefthymiou, Petros Zormpas, Stefan Seewald, Maria Zachou, Federico Barbaro, Michel Kahaleh, Gianluca Andrisani, Shaimaa Elkholy, Mohamed El-Sherbiny, Yoriaki Komeda, Raghavendra Yarlagadda, Georgios Tziatzios, Kareem Essam, Hany Haggag, Gregorios Paspatis, Georgios Mavrogenis
{"title":"Endoscopic Local Excision (ELE) with Knife-Assisted Resection (KAR) Techniques Followed by Adjuvant Radiotherapy and/or Chemotherapy for Invasive (T1bsm2,3/T2) Early Rectal Cancer: A Multicenter Retrospective Cohort.","authors":"George Tribonias, Apostolis Papaefthymiou, Petros Zormpas, Stefan Seewald, Maria Zachou, Federico Barbaro, Michel Kahaleh, Gianluca Andrisani, Shaimaa Elkholy, Mohamed El-Sherbiny, Yoriaki Komeda, Raghavendra Yarlagadda, Georgios Tziatzios, Kareem Essam, Hany Haggag, Gregorios Paspatis, Georgios Mavrogenis","doi":"10.3390/jcm13226951","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Resected rectal polyps with deep invasion into the submucosa (pT1b-sm2,3) or the muscle layer (pT2) are currently confronted with surgery due to non-curative resection. <b>Aims:</b> We evaluated the efficacy, safety, and locoregional control of adjuvant radiotherapy (RT) and/or chemotherapy (CT) following endoscopic KAR (knife-assisted resection) in patients with invasive early rectal cancers who are unwilling or unsuitable for additional surgical resection. <b>Methods:</b> Fifty-one patients with early rectal cancers, pT1b or pT2, underwent post-resection adjuvant RT and/or CT in 15 centers worldwide. \"En bloc\" macroscopic resection, R0 resection, recurrence rate, and adverse events following resection and adjuvant therapy were recorded in a multicenter retrospective cohort study. <b>Results:</b> Diagnostic staging (38/51, 75%) was the main reason for ELE. Macroscopic \"en bloc\" resection was demonstrated in 50/51 (98%), with an average follow-up of 20.6 months. Endoscopic recurrence occurred in 7/51 (13.7%) of patients, with mean time for diagnosis of recurrence at 8.9 months. Adjuvant therapy consisted of RT in 49.0% (25/51), CT in 11.8% (6/51), and combined CRT in 39.2% (20/51) of the cases. Perforation, severe post-procedural bleeding, and incontinence were the most frequent complications. The absence of superficial ulceration was associated with macroscopic complete resection, while the lesions with lower budding stage, clear lateral margins, lesion size < 40 mm, and needle-type knife used were associated with less endoscopic recurrencies. <b>Conclusions:</b> Our data investigated adjuvant RT and/or CT after endoscopic KAR of infiltrative rectal cancers (pT1bsm2,3-pT2) as being safe and effective for locoregional control and providing a non-surgical treatment option for patients with a non-curative resection.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"13 22","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jcm13226951","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Resected rectal polyps with deep invasion into the submucosa (pT1b-sm2,3) or the muscle layer (pT2) are currently confronted with surgery due to non-curative resection. Aims: We evaluated the efficacy, safety, and locoregional control of adjuvant radiotherapy (RT) and/or chemotherapy (CT) following endoscopic KAR (knife-assisted resection) in patients with invasive early rectal cancers who are unwilling or unsuitable for additional surgical resection. Methods: Fifty-one patients with early rectal cancers, pT1b or pT2, underwent post-resection adjuvant RT and/or CT in 15 centers worldwide. "En bloc" macroscopic resection, R0 resection, recurrence rate, and adverse events following resection and adjuvant therapy were recorded in a multicenter retrospective cohort study. Results: Diagnostic staging (38/51, 75%) was the main reason for ELE. Macroscopic "en bloc" resection was demonstrated in 50/51 (98%), with an average follow-up of 20.6 months. Endoscopic recurrence occurred in 7/51 (13.7%) of patients, with mean time for diagnosis of recurrence at 8.9 months. Adjuvant therapy consisted of RT in 49.0% (25/51), CT in 11.8% (6/51), and combined CRT in 39.2% (20/51) of the cases. Perforation, severe post-procedural bleeding, and incontinence were the most frequent complications. The absence of superficial ulceration was associated with macroscopic complete resection, while the lesions with lower budding stage, clear lateral margins, lesion size < 40 mm, and needle-type knife used were associated with less endoscopic recurrencies. Conclusions: Our data investigated adjuvant RT and/or CT after endoscopic KAR of infiltrative rectal cancers (pT1bsm2,3-pT2) as being safe and effective for locoregional control and providing a non-surgical treatment option for patients with a non-curative resection.

侵袭性(T1bsm2,3/T2)早期直肠癌采用内镜下局部切除术(ELE)和刀辅助切除术(KAR)技术并辅以放疗和/或化疗:多中心回顾性队列。
背景:已切除的直肠息肉深度侵犯粘膜下层(pT1b-sm2,3)或肌层(pT2),目前因无法进行根治性切除而面临手术治疗。目的:我们评估了不愿意或不适合进行额外手术切除的浸润性早期直肠癌患者在接受内镜KAR(刀辅助切除术)后进行辅助放疗(RT)和/或化疗(CT)的疗效、安全性和局部控制情况。研究方法全球 15 个中心的 51 例 pT1b 或 pT2 早期直肠癌患者接受了切除术后辅助 RT 和/或 CT 治疗。在一项多中心回顾性队列研究中记录了 "En bloc "大体切除、R0切除、复发率以及切除和辅助治疗后的不良反应。研究结果诊断性分期(38/51,75%)是 ELE 的主要原因。50/51(98%)例患者接受了显微镜下 "全块 "切除术,平均随访20.6个月。7/51(13.7%)例患者出现内镜下复发,诊断复发的平均时间为 8.9 个月。49.0%的患者(25/51)接受了RT辅助治疗,11.8%的患者(6/51)接受了CT辅助治疗,39.2%的患者(20/51)接受了CRT联合治疗。穿孔、术后严重出血和大小便失禁是最常见的并发症。无表皮溃疡与宏观完全切除有关,而病灶萌芽期较低、侧缘清晰、病灶大小小于40毫米、使用针型刀与内镜下复发率较低有关。结论我们的数据研究了浸润性直肠癌(pT1bsm2,3-pT2)内镜下 KAR 术后辅助 RT 和/或 CT 的安全性和有效性,以控制局部病变,并为非根治性切除患者提供非手术治疗选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Medicine
Journal of Clinical Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
5.70
自引率
7.70%
发文量
6468
审稿时长
16.32 days
期刊介绍: Journal of Clinical Medicine (ISSN 2077-0383), is an international scientific open access journal, providing a platform for advances in health care/clinical practices, the study of direct observation of patients and general medical research. This multi-disciplinary journal is aimed at a wide audience of medical researchers and healthcare professionals. Unique features of this journal: manuscripts regarding original research and ideas will be particularly welcomed.JCM also accepts reviews, communications, and short notes. There is no limit to publication length: our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信